Start-up and steel. Typically, those two words don't go together. But Bradlay Pryde isn’t your typical entrepreneur. He sits down with the guys to talk about the early days when he founded SteelNow and what comes next. 

Brad is the founder of SteelNow, and current co-founder of OneThree Biotech. OneThree is redesigning drug discovery with biology driven AI. Onethree has created one of the only AI platforms with multiple clinically validated predictions and the most diverse, fully integrated database. Its technology has created higher clinical success rates for our partners and an internal oncology pipeline.

https://onethree.bio/